
First Trust Multi-Manager Small Cap Opportunities ETF (MMSC)
ETF overview
This Exchange Traded Fund (ETF) aims to achieve significant long-term appreciation in its capital. Under typical market circumstances, it allocates a minimum of 80% of its total assets, potentially including funds borrowed for investment, to equity securities issued by smaller companies. These small-capitalization firms are defined as those whose market value, at the time of initial investment, falls within the range of companies comprising the Russell 2000 Growth Index as established during its most recent rebalancing. The fund's holdings are primarily composed of common shares from corporations headquartered in the United States, in addition to non-U.S. companies whose stocks are principally traded on U.S. exchanges. Through a multi-manager strategy, the ETF endeavors to access the growth-oriented portion of the small-cap equity market by integrating the expertise of various portfolio management teams.
Fund facts
- Expense ratio
- 0.95%
- Fund assets
- 50.75M USD (all share classes)
- Issuer
- First Trust
- Inception date
- Oct 13, 2021
- Number of holdings
- 202
Breakdown
Holdings (202)
| Name | Ticker | Weight |
|---|---|---|
| Xometry, Inc. (Class A) | XMTR | 1.70% |
| Zeta Global Holdings Corp. (Class A) | ZETA | 1.57% |
| Twist Bioscience Corporation | TWST | 1.51% |
| Repligen Corporation | RGEN | 1.51% |
| FirstCash Holdings, Inc. | FCFS | 1.50% |
| JFrog Ltd. | FROG | 1.47% |
| Varonis Systems, Inc. | VRNS | 1.37% |
| Guardant Health, Inc. | GH | 1.35% |
| Travere Therapeutics, Inc. | TVTX | 1.29% |
| Halozyme Therapeutics, Inc. | HALO | 1.16% |
| and 189 more | ||
Historical returns do not guarantee future returns. This is not investment advice.

First Trust Multi-Manager Small Cap Opportunities ETF (MMSC)
- Expense ratio
- 0.95%
- Fund assets
- 50.75M USD (all share classes)
- Issuer
- First Trust
- Inception date
- Oct 13, 2021
- Number of holdings
- 202
| Name | Ticker | Weight |
|---|---|---|
| Xometry, Inc. (Class A) | XMTR | 1.70% |
| Zeta Global Holdings Corp. (Class A) | ZETA | 1.57% |
| Twist Bioscience Corporation | TWST | 1.51% |
| Repligen Corporation | RGEN | 1.51% |
| FirstCash Holdings, Inc. | FCFS | 1.50% |
| JFrog Ltd. | FROG | 1.47% |
| Varonis Systems, Inc. | VRNS | 1.37% |
| Guardant Health, Inc. | GH | 1.35% |
| Travere Therapeutics, Inc. | TVTX | 1.29% |
| Halozyme Therapeutics, Inc. | HALO | 1.16% |
| and 189 more | ||
This Exchange Traded Fund (ETF) aims to achieve significant long-term appreciation in its capital. Under typical market circumstances, it allocates a minimum of 80% of its total assets, potentially including funds borrowed for investment, to equity securities issued by smaller companies. These small-capitalization firms are defined as those whose market value, at the time of initial investment, falls within the range of companies comprising the Russell 2000 Growth Index as established during its most recent rebalancing. The fund's holdings are primarily composed of common shares from corporations headquartered in the United States, in addition to non-U.S. companies whose stocks are principally traded on U.S. exchanges. Through a multi-manager strategy, the ETF endeavors to access the growth-oriented portion of the small-cap equity market by integrating the expertise of various portfolio management teams.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free